Stocks · US
AVTR
XNYS
Avantor, Inc.
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E—
P/B1.90x
P/S1.63x
EPS$-0.85
ROE-10.27%
ROA-4.98%
Dividend yield0.00%
EV/EBITDA15.57x
Debt/Equity0.66
Free cash flow$455M
Returns and 52-week range
1W+1.25%
1M+3.07%
3M+58.09%
6M+92.88%
1Y+7.98%
YTD+34.64%
52W high$16.38
52W low$7.26
From 52W high-5.77%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Repligen Corp | $10.7B | 257.46 | 5.06 | +4.33% |
| 유니버설 헬스 서비시스 | $10.4B | 6.80 | 1.38 | +4.38% |
| 쿠퍼 | $10.8B | 18.93 | 1.30 | -18.91% |
| GLOBUS MEDICAL INC | $10.3B | 19.20 | 2.16 | -2.38% |
| Vaxcyte, Inc. Common Stock | $11.0B | — | 3.98 | +9.06% |
| Bio-Rad Laboratories, Inc.Class A | $10.2B | 45.66 | 1.42 | -4.48% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.